Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.

Saved in:
Bibliographic Details
Title: Interferon-α Nasal Spray Prophylaxis Reduces COVID-19 in Cancer Patients: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Authors: Yong MK; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Thursky K; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Crane M; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Spelman T; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Health Services Research, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Mahar RK; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.; Methods and Implementation Support for Clinical and Health (MISCH) Research Hub, The University of Melbourne, Melbourne, Victoria, Australia.; Clinical Epidemiology and Biostatistics Unit, Murdoch Children's Research Institute, Parkville, Victoria, Australia., Simpson JA; Biostatistics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.; Methods and Implementation Support for Clinical and Health (MISCH) Research Hub, The University of Melbourne, Melbourne, Victoria, Australia., Scott AM; Department of Molecular Imaging and Therapy, Austin Health, Heidelberg, Victoria, Australia.; Olivia Newton-John Cancer Research Institute, Tumour Targeting Laboratory, Heidelberg, Victoria, Australia.; Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; School of Cancer Medicine, LaTrobe University, Melbourne, Victoria, Australia., Harrison SJ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Szer J; Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Victoria, Australia., Pellegrini M; Walter and Eliza Hall Institute of Medical Research, Division of Infectious Diseases and Immune Defence, Parkville, Victoria, Australia.; Department of Medical Biology, University of Melbourne, Melbourne, Victoria, Australia.; Centenary Institute, Executive Director, Camperdown, New South Wales, Australia.; Faculty of Heath and Medical Sciences, University of Sydney, Camperdown, New South Wales, Australia., Lingaratnam S; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Pharmacy Department, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Pang KC; Clinical Sciences, Murdoch Children's Research Institute, Parkville, Victoria, Australia.; Department of Adolescent Medicine, Royal Children's Hospital, Parkville, Victoria, Australia.; Department of Paediatrics, University of Melbourne, Parkville, Victoria, Australia., Tennakoon S; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Sim BZ; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Blyth E; Department of Haematology, Westmead Hospital, Westmead, New South Wales, Australia.; Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia., Gan HK; Department of Oncology, Austin Hospital, Heidelberg, Victoria, Australia., Quach H; Faculty of Medicine, University of Melbourne, Melbourne, Victoria, Australia.; Department of Haematology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia., McIntosh MP; Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Melbourne, Victoria, Australia., Page H; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Woolstencroft R; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Slavin M; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.; Department of Infectious Diseases, Royal Melbourne Hospital, Melbourne, Victoria, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2026 Feb 25; Vol. 82 (2), pp. e208-e216.
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1537-6591
DOI:10.1093/cid/ciaf409